
Congressional Committees Examine Medicare-related Tax Changes
Last month, two congressional committees debated policy changes at the intersection of Medicare rules and federal tax law, though the
Join Us Live for a Discussion on Medicare, Democracy, and the Future of Health Care
Medicare Watch articles are featured in Medicare Rights’ weekly newsletter, which helps readers stay updated on Medicare policy and advocacy developments and learn about changes in Medicare benefits and rules. Subscribe now by visiting www.medicarerights.org/newsletters.

Last month, two congressional committees debated policy changes at the intersection of Medicare rules and federal tax law, though the

Last week, the Centers for Medicare & Medicaid Services (CMS) announced that all of the manufacturers of the first 10

This week, we at Medicare Rights released our annual Medicare Trends Report, which features key challenges facing people with Medicare

Last week, we covered new KFF research on Medicare Advantage (MA) television advertisements that aired during the Fall of 2022,

In advance of the upcoming Medicare Fall Open Enrollment period, beginning October 15, the Biden-Harris administration announced that Medicare Advantage

Two new KFF research reports capture the prolific—and often problematic—nature of Medicare Advantage (MA) television advertisements during Medicare’s fall open

This week, the Centers for Medicare & Medicaid Services (CMS) finalized a long-awaited rule that will make it easier for

A new survey from the Commonwealth Fund examines beneficiary experiences with marketing outreach from private Medicare Advantage (MA), Medigap, and

This week, Medicare Rights submitted comments on three proposed rules. One would improve access to needed services. A second would

On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will

Last month, two congressional committees debated policy changes at the intersection of Medicare rules and federal tax law, though the

Last week, the Centers for Medicare & Medicaid Services (CMS) announced that all of the manufacturers of the first 10

This week, we at Medicare Rights released our annual Medicare Trends Report, which features key challenges facing people with Medicare

Last week, we covered new KFF research on Medicare Advantage (MA) television advertisements that aired during the Fall of 2022,

In advance of the upcoming Medicare Fall Open Enrollment period, beginning October 15, the Biden-Harris administration announced that Medicare Advantage

Two new KFF research reports capture the prolific—and often problematic—nature of Medicare Advantage (MA) television advertisements during Medicare’s fall open

This week, the Centers for Medicare & Medicaid Services (CMS) finalized a long-awaited rule that will make it easier for

A new survey from the Commonwealth Fund examines beneficiary experiences with marketing outreach from private Medicare Advantage (MA), Medigap, and

This week, Medicare Rights submitted comments on three proposed rules. One would improve access to needed services. A second would

On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will